Evomela

DRUG2 trials

Sponsors

Medical College of Wisconsin, Koen van Besien

Conditions

Hematological MalignancyMultiple Myeloma

Early Phase 1

Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma

WithdrawnNCT05013437

Koen van BesienMultiple Myeloma

Start: 2023-09-30End: 2024-03-31Updated: 2024-04-02

Phase 2

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

CompletedNCT03159702

Medical College of WisconsinHematological Malignancy, Multiple Myeloma

Start: 2017-12-08End: 2025-12-08Updated: 2026-01-27